GE Healthcare has invested $40 million this year in the Elbit Medical ultrasound device unit, and is increasing its stake to 40%.
Elbit Medical Technologies Ltd. (TASE: EMTC) announced today that its subsidiary InSightec Image Guided Treatment Ltd. has signed a memorandum of understanding with GE Healthcare. Under the agreement, GE Healthcare will invest $27.5 million in the company. Insightec develops MRI-guided focused ultrasound devices for the treatment of uterine fibroids, tumors, and neurological disorders, such as essential tremor‚ neuropathic pain and Parkinson’s disease.
GE Healthcare invested $13.5 million in Insightec in February and currently holds an 18% stake in the company while Elbit Medical has a 64.3% stake. The latest investment will be in the form of a loan convertible to shares, in two tranches, according to a company valuation of $102.5 million after money. At the end of the process, Elbit will reduce its stake in Insightec to 50%, while GE Healthcare will raise its stake to 40%. Elbit will lose its controlling stake but remain the largest shareholder.
Published by Globes [online], Israel business news - www.globes-online.com - on May 28, 2012
© Copyright of Globes Publisher Itonut (1983) Ltd. 2012
You comment was recieved and soon will be published.
Load more comments